INTRODUCTION {#S2}
============

Striated muscle contraction results from transient interactions between myosin-containing thick and actin-containing thin filaments. Contractile regulation, throughout the animal kingdom, is achieved by Ca^2+^-dependent modulation of myosin cross-bridge cycling on actin by the thin filament troponin-tropomyosin complex ([@R35]; [@R58]; [@R11]; [@R34]). The complex consists of an elongated tropomyosin (Tm) dimer and the troponin C (TnC, calcium binding), troponin I (TnI, inhibitory), and troponin T (TnT, Tm binding) subunits of troponin (Tn). Tm is a modular protein consisting of seven tandem pseudo-repeating motifs designed to bind seven successive actin monomers along the thin filament ([@R10]; [@R27]; [@R39]). The continuous Tn-Tm complexes adopt various states characterized by different average Tm positions that govern the access of myosin binding sites and hence force production ([@R58]; [@R34]). Under low Ca^2+^ conditions, TnI binds to actin and constrains Tn-Tm to the B state, in which Tm sterically blocks and limits myosin binding. Upon activation, Ca^2+^ binds to TnC, which triggers TnI release from actin and Tm movement away from myosin binding sites, resulting in the C state. Initial myosin binding further displaces Tm, which increases myosin accessibility along actin to establish the open (M) state and promotes cooperative activation of contraction. Tm can oscillate dynamically between the states at all Ca^2+^ levels, and it is the average azimuthal location of this equilibrium that is normally determined by Tn, Ca^2+^, and myosin ([@R43]; [@R42]; [@R52]).

The association of Tm with actin is largely electrostatic ([@R10]; [@R39]; [@R3]). Models of filamentous actin and Tm (F-actin-Tm), in the absence of Tn (i.e., the A state), have been proposed based on molecular evolutionary and mutational analysis, computational chemistry, and electron microscopy (EM) reconstructions ([@R2], [@R3]; [@R39]; [@R64]). These models define a conserved F-actin-Tm binding interface that is characterized by clusters of charged residues on F-actin, which make favorable contacts with each consecutive Tm pseudo-repeat. The electrostatic interactions place the dimer in a location that is close to its B-state position on regulated F-actin-Tn-Tm filaments when pinned down by TnI at low Ca^2+^ and establish an energetically stable conformation ([@R39]; [@R3]; [@R38]). In particular, K326, K328, and R147 on actin appear to interact with acidic residues of each repetitive motif along Tm's entire length, associations that in muscle are likely essential for helping establish an energy basin to bias Tm to an inhibitory position ([@R50]).

Because precisely coordinated communication among individual components is compulsory for proper contractile regulation, it follows that mutations at or near thin filament subunit interfaces can disrupt its function and initiate myopathy. For example, the loci of many of the \~100 thin filament mutations that cause hypertrophic cardiomyopathy (HCM) are found at intermolecular surfaces ([@R57]). HCM is a clinically diverse, autosomal dominant disease of cardiac muscle that afflicts 1:500 of the general population ([@R41]). It is characterized by abnormal thickening of the heart, myocellular disarray, arrhythmias, and altered Ca^2+^ homeostasis. However, the earliest signs of disease are hyperdynamic contractile properties and diastolic dysfunction, which precede ventricular hypertrophy and have been shown to be essential for HCM pathobiology ([@R21]). Diastolic dysfunction is associated with elevated filling pressures due to impaired relaxation and increased myocardial stiffness ([@R29]; [@R16]).

In 1999, the first α-cardiac actin (*ACTC1*) mutation linked to HCM was reported ([@R45]). Expression of the *ACTC1* A295S variant engendered highly penetrant yet heterogeneous disease phenotypes among family members. Only one of 13 individuals was asymptomatic, whereas nine were phenotypically assigned with major HCM and three were phenotypically assigned with minor HCM. Despite its identification nearly two decades ago, efforts to characterize A295S actin have been limited and failed to resolve any disruptions in in vitro transcription and/or translation, folding efficiency, or actomyosin ATPase activity of mutant proteins ([@R60]; [@R17]). Overall, such clinical heterogeneity, the absence of mutation-induced in vitro effects, and a lack of animal models limits meaningful genotype-phenotype correlations for predicting patient outcomes and our understanding of the molecular basis of disease ([@R57]). However, model organisms that minimize confounding genetic and environmental factors to curtail phenotypic variability, and permit analysis from the molecular through the organ level, can help resolve the intricate origins of myopathies.

Here, we used *Drosophila melanogaster* as our primary experimental model for comprehensive in vivo, in situ, in vitro, and in silico analysis of the *ACTC1* A295S HCM-causing mutation. We tested the hypothesis that the mutation perturbs critical associations between nearby actin residues K326, K328, and R147, termed the A-triad, and Tm, which disrupts contractile inhibition, stimulates hyperdynamic and excessive tension generation, and consequently initiates disease. The variant would therefore be expected to yield a molecular phenotype characterized by inadequate Tm-based blocking of myosin binding on thin filaments. When expressed in the fly heart, A295S mutant actin significantly decreased cardiac output, prolonged systolic intervals, and elicited diastolic dysfunction by increasing actively cycling cross-bridges without affecting the resting cellular Ca^2+^ milieu. A295S actin expression in the indirect flight muscle (IFM) also induced hypercontraction and enhanced Ca^2+^ sensitivity of reconstituted thin filament sliding. Computational modeling indicated that the *ACTC1* A295S HCM mutation changed the orientation of A-triad residues and their interactions with Tm, which would destabilize the energetically favored inhibitory A/B state and may bias Tm toward the C-state configuration. Demonstration that possible subtle changes in F-actin-Tm interactions promote discernable contractile disinhibition emphasizes the value of *Drosophila* models for providing a mechanistic basis for proximal causes of myocardial disease. Thus, our efforts increase understanding of basic thin filament biology and help elucidate the pathogenesis of a complex cardiac disorder.

RESULTS {#S3}
=======

The A295S Mutation Resides Proximal to the Highly Conserved Actin A-Triad {#S4}
-------------------------------------------------------------------------

Human and *Drosophila* actins are encoded by six highly homologous genes. As found in vertebrates, flies express cardiac and skeletal muscle-specific isoforms. *Act57B* is one of two sarcomeric actin genes expressed in the adult fly heart, while *Act88F* encodes all sarcomeric actin of the IFM ([@R13]; [@R56]; [@R26]). The cardiac and skeletal isoforms differ in only a few amino acids within and between species ([Figure 1A](#F1){ref-type="fig"}). K326, K328, and R147, which based on F-actin-Tm models, make multiple favorable electrostatic contacts with Tm, are exceptionally well conserved. Analysis of more than 800 actin sequences, from vertebrates and invertebrates, revealed 100% fidelity of these basic residues ([Figure S1](#SD1){ref-type="supplementary-material"}). This supports a vital role for these amino acids in actin function and potentially, in striated muscle thin filaments, in Tn-Tm-mediated regulation of contraction. To emphasize the importance of these residues in establishing the A state of F-actin-Tm and, in principle, in contractile regulation of striated muscle, we have designated these amino acids as the A-triad. A295 is centered just behind the A-triad in the actin subunit structure ([Figure 1B](#F1){ref-type="fig"}). Therefore, amino acid substitutions at this locus may induce propagated effects that influence the association of the A-triad with corresponding residues along Tm and influence its capacity to impede myosin binding.

A295S Actin Incorporates Uniformly along *Drosophil*a Cardiac Thin Filaments {#S5}
----------------------------------------------------------------------------

*Drosophila* has a linear cardiac tube that consists of a single layer of cardiomyocytes and is highly reminiscent of the primitive vertebrate embryonic heart ([Figure 2A](#F2){ref-type="fig"}) ([@R44]). The relative simplicity of the fly heart, combined with an array of tools to manipulate the fly genome, provide unique opportunities to examine how thin filament mutations affect cardiac muscle and drive disease. Using the PhiC31 integrase system ([@R22]), we generated several transgenic lines that permit examination of the muscle-specific effects of wild-type versus A295S mutant actin expression at multiple levels. PhiC31-mediated transgenesis ensured each gene integrated at an identical, predetermined genomic location. Thus, our results are directly comparable and phenotypic differences in control versus mutant flies were immediately attributed to the single amino acid substitution in actin. Heart-specific expression of transgenes was achieved via the Gal4-upstream activating sequence (UAS) expression system ([@R8]). Flies harboring the *Hand^4.2^-Gal4* driver were crossed with flies containing constructs consisting of an *UAS* followed by an *Act57B* transgene. The progenies inherit both genes and express the *UAS-Act57B* transgene exclusively in the cardiac tube, which was confirmed by direct visualization of fluorescent signals from *Hand^4.2^-Gal4* \> *UAS-Act57B^GFP.WT^* (abbr.*Hand* \> *Act57B^GFP.WT^*) flies ([Figure 2A](#F2){ref-type="fig"}). Closer examination revealed clear, striated GFP signals from the hearts of *Hand* \> *Act57B^GFP.WT^* and *Hand* \> *Act57B^GFP.A295S^ Drosophila* ([Figures 2B and 2C](#F2){ref-type="fig"}). At 100× magnification, GFP signals from both lines were seen overlapping congruently with tetramethylrhodamine (TRITC)-phalloidin actin signals ([Figures 2C and 2D](#F2){ref-type="fig"}). Act57B^GFP.A295S^ actin was not excluded from sarcomeres and did not accumulate in localized sub-sarcomeric regions. These data illustrate homogeneous co-polymerization of Act57B^GF-P.A295S^ mutant actin with endogenous cardiac actin evenly, along the entire length of the thin filaments, in a manner indistinguishable from that of Act57B^GFP.WT^ actin.

The *ACTC1* A295S HCM Mutation Induces Cardiomyopathy in *Drosophila* {#S6}
---------------------------------------------------------------------

High-speed video microscopy and semi-automated motion analysis were used to investigate the consequences of the HCM actin mutation on *Drosophila* cardiac tubes. We analyzed beating hearts of females expressing *UAS-Act57B^WT^* versus *UAS-Act57B^A295S^* transgenes that lacked GFP to eliminate confounding effects caused by the N-terminally located moiety ([Figure S2A](#SD1){ref-type="supplementary-material"}). M-mode kymograms, which illustrate heart wall movement over time, suggested mutation-induced alterations in cardiac dimensions and contractile dynamics in three-week-old flies ([Figures 3A and 3B](#F3){ref-type="fig"}). *Hand* \> *Act57B^A295S^* hearts were characterized by restricted diameters and prolonged systolic periods relative to controls.

We quantified the effects of *Act57B^A295S^* mutant actin expression on several cardiac parameters relative to wild-type actin expression and to endogenous actin expression in non-transgenic controls (the progeny of *Hand × yw*), from one through seven weeks of age ([Figure 3C](#F3){ref-type="fig"}; [Table S1](#SD1){ref-type="supplementary-material"}). As shown previously, cardiac output, diastolic and systolic diameters, and fractional shortening progressively decreased among all genotypes over time ([@R7]). However, *Hand* \> *Act57B^A295S^ Drosophila* exhibited significantly diminished output relative to controls. This reduction was due to restricted diastolic and systolic diameters. Moreover, the effect of mutant actin expression on diastolic diameters was greater than that on systolic diameters, which resulted in a significant decrease in fractional shortening versus controls. Overall, as observed in a cohort of HCM patients with myosin or TnI mutations ([@R33]), *Hand* \> *Act57B^A295S^* hearts demonstrated a restrictive phenotype and were unable to adequately relax during diastole.

We also evaluated the myogenic cardiac contractile dynamics for *Hand* \> *Act57B^A295S^* relative to *Hand* \> *Act57B^WT^* and non-transgenic actin controls. The heart period, which is the combined length of time required for a single diastolic and ensuing systolic event of the cardiac cycle, significantly increased with age for all lines but did not differ among genotypes ([Figure 3C](#F3){ref-type="fig"}). However, normalization of the systolic interval to the heart period (SI/HP) for each line, which illustrates the proportion of time spent generating active tension during the cardiac cycle, revealed the A295S actin mutation induced an increase in the SI/HP ratio relative to controls at all ages.

Thus, analogous to what is seen during early stages of HCM, which are characterized by diastolic dysfunction and hyper-dynamic contractile properties ([@R21]), the A295S actin mutation perturbs the heart's ability to reestablish resting diastolic volumes and it prolongs tension-generating periods. All preceding findings were verified using a second, independent pair of transgenic *Drosophila* lines ([Figures S2B and S2C](#SD1){ref-type="supplementary-material"}; [Table S2](#SD1){ref-type="supplementary-material"}).

A295S Actin Reduces Heart Diameters during Diastole by Increasing Ca^2+^-Independent Actomyosin Associations {#S7}
------------------------------------------------------------------------------------------------------------

Altered Ca^2+^ homeostasis is frequently observed in HCM, and diastolic dysfunction, a hallmark of HCM, can be partly attributed to elevated diastolic Ca^2+^ levels that promote actomyosin associations and impair relaxation. The inherent nature of the *Drosophila* heart tube, which is formed by opposing rows of cardiomyocytes joined by intercellular junctions ([@R44]), provides unique opportunities to assess diastolic properties with single-cell resolution, in situ, in the native context of the functioning organ ([@R61]; [@R31]). To determine a contribution of potentially elevated diastolic Ca^2+^ to shortened *Hand* \> *Act57B^A295S^* myocytes and thus to reduced cardiac diameters, we incubated live hearts of all genotypes in a solution containing 10 mM EGTA and 100 μM EGTA,AM. EGTA,AM is a cell-permeant acetoxymethyl ester of the Ca^2+^ chelator EGTA, which passively enters cells, is hydrolyzed by intracellular esterases, and produces EGTA. Upon EGTA/EGTA,AM incubation, rhythmic contractions ceased ([Figure 4A](#F4){ref-type="fig"}). Relative to those established during diastole, all lines experienced a slight yet significant \~2.5% increase in diameters upon chelation of extra- and intracellular Ca^2+^ ([Figures 4B and 4C](#F4){ref-type="fig"}). Therefore, minor amounts of intracellular diastolic Ca^2+^ likely trigger actomyosin interactions and produce slightly contracted cardiomyocytes. Comparison of the responses ([Figure 4C](#F4){ref-type="fig"}), however, revealed no significant difference in the average change in cardiac diameters among *Hand × yw* (Δ = 1.70 ± 0.08 μm), *Hand* \> *Act57B^WT^* (Δ = 1.88 ± 0.09 μm), and *Hand* \> *Act57B^A295S^* (Δ = 1.85 ± 0.06 μm). This implies that a similar diastolic Ca^2+^ level is shared among the genotypes, which contributes equally to resting tension, and that the significantly restricted *Hand* \> *Act57B^A295S^* heart diameters do not result from elevated resting Ca^2+^ causing excessive myocyte shortening. Unperturbed Ca^2+^ handling was also supported by qPCR analysis ([Figure S3](#SD1){ref-type="supplementary-material"}), which revealed no differences in transcript levels of L-type Ca^2+^ channels, ryanodine receptors, sarco/endoplasmic reticulum calcium ATPase (SERCA), Na^+^/Ca^2+^ exchangers, or inositol triphosphate (IP~3~) receptors between the lines. Thus, the cardiomyocyte Ca^2+^-handling biosignature appeared normal following *Act57B^A295S^* actin expression.

Blebbistatin, a small-molecule inhibitor of several striated muscle myosins, impedes actomyosin interaction in cardiac preparations from multiple species, including flies ([@R20]; [@R61]). Subsequent analysis verified that the addition of blebbistatin to EGTA/EGTA,AM-treated hearts evoked a second significant increase in diameters across the wall of all genotypes ([Figure 4B](#F4){ref-type="fig"}). This suggests that the initial chelation of intracellular Ca^2+^ does not induce complete relaxation of *Drosophila* cardiomyocytes and that under such Ca^2+^-free conditions, Tm-based steric prevention of actomyosin interactions is incomplete. Hence, in addition to those stimulated by trace amounts of free Ca^2+^, a small population of residual cross-bridges is actively cycling, generating force, reducing cardiomyocyte length, and establishing basal myocardial tone during diastole. To evaluate the relative proportion of these Ca^2+^-independent, unimpeded, force-generating, diastolic cross-bridges, we compared the blebbistatin-induced diameter changes among all lines. The average cardiac diameters for *Hand* × *yw* and *Hand* \> *Act57B^WT^* following blebbistatin treatment were \~2% greater (Δ = 1.61 ± 0.05 and 1.72 ± 0.10 μm, respectively) than those determined during EGTA/EGTA,AM incubation ([Figures 4B--4D](#F4){ref-type="fig"}). However, the average cardiac diameter for *Hand* \> *Act57B^A295S^* following blebbistatin treatment was \~8% greater (Δ = 5.47 ± 0.26 μm) than that determined during EGTA/EGTA,AM incubation ([Figures 4B--4D](#F4){ref-type="fig"}). Comparing the diameter changes among the genotypes ([Figure 4D](#F4){ref-type="fig"}) revealed the response to blebbistatin was significantly greater for *Hand* \> *Act57B^A295S^* hearts relative to that for controls. These observations are consistent with diastolic dysfunction and restrictive physiology that are unrelated to resting Ca^2+^ levels but rather due to excessively disinhibited Ca^2+^-independent cross-bridge cycling, enhanced basal tension, and incomplete relaxation for *Hand* \> *Act57B^A295S^* mutant hearts. Thus, the A295S actin mutation could destabilize Tm positioning such that it inadequately blocks myosin binding at rest, causing excessive tension and myocyte shortening that restricts proper filling, even in the absence of disrupted Ca^2+^ handling.

A295S Actin Impairs *Drosophila* Flight Ability and Promotes Skeletal Muscle Hypercontraction {#S8}
---------------------------------------------------------------------------------------------

*Drosophila* IFMs are well suited for mechanical and structural analyses, are exquisitely sensitive to sarcomeric mutations, and provide sufficient material for biochemical and biophysical investigation ([@R4]; [@R6]; [@R54]; [@R11], [@R12]). To study the effects of the HCM mutation on the IFM, we created *Act88F^WT^* and *Act88F^A295S^* transgenic flies. Different doses of transgenic versus endogenous actin were achieved by back-crossing the transgene into a flightless, *Act88F* null strain. Compared to *w^1118^* non-transgenic and *Act88F^WT^*/+ controls, *Act88F^A295S^*/+ heterozygous flies showed a slight but significant decrease in flight ability, as determined by standard metrics ([Figure S4A](#SD1){ref-type="supplementary-material"}). The capacity for typical upward flight appeared blunted in the mutants. *Act88F^WT^*/+ *Drosophila* also displayed modest flight impairment relative to *w^1118^*.

To enhance our ability to characterize organismal behavior, we employed digital inline holography to comprehensively phenotype flight kinematics ([Figure S5](#SD1){ref-type="supplementary-material"}). We computed three-dimensional trajectories for ascending *w^1118^*, *Act88F^WT^*/+, and *Act88F^A295S^*/+ *Drosophila* and compared free-flying velocity and acceleration parameters ([Figure 5A](#F5){ref-type="fig"}). Both *Act88F^WT^*/+ (0.42 ± 0.01 m/s, 27.02 ± 1.15 rad/s) and *Act88F^A295S^*/+ (0.36 ± 0.02 m/s, 22.90 ± 1.40 rad/s) transgenic lines displayed significantly lower overall and angular velocities relative to *w^1118^* (0.45 ± 0.01 m/s, 31.51 ± 1.22 rad/s) ([Figure 5B](#F5){ref-type="fig"}). However, *Act88F^A295S^*/+ (3.38 ± 0.32 m/s^2^) exhibited significantly reduced acceleration relative to both *Act88F^WT^*/+ (4.60 ± 0.26 m/s^2^) and *w^1118^* (5.00 ± 0.27 m/s^2^). Likewise, centripetal acceleration for *Act88F^A295S^*/+ (8.43 ± 0.74 m/s^2^) was significantly lower than that for *Act88F^WT^*/+ (11.38 ± 0.57 m/s^2^) and *w^1118^* (14.48 ± 0.68 m/s^2^). Moreover, because the body weights of all genotypes were identical ([Figure S4B](#SD1){ref-type="supplementary-material"}), and given that the mutants exhibited reduced acceleration, A295S actin expression appears to compromise the amount of IFM force development during upward flight. Despite clear flight impairment for *Act88F^A295S^*/+ heterozygotes, no discernable gross morphological disruptions were observed in their IFMs, relative to *w^1118^* and *Act88F^WT^*/+, that could account for the altered behavior ([Figure 6A](#F6){ref-type="fig"}).

Homozygous expression of wild-type transgenic actin in *Act88F^WT^*/*Act88F^WT^ Drosophila* did not rescue the flightless phenotype associated with the *Act88F* null strain ([Figure S4A](#SD1){ref-type="supplementary-material"}), potentially due to an insufficient degree of transgene expression ([@R5]). IFM development and morphology, however, were indistinguishable between *Act88F^WT^*/*Act88F^WT^* and *w^1118^* non-transgenic controls ([Figure 6A](#F6){ref-type="fig"}). *Act88F^A295S^/Act88F^A295S^ Drosophila* were similarly flightless ([Figure S4A](#SD1){ref-type="supplementary-material"}), yet their IFMs exhibited destructive hypercontraction ([Figure 6A](#F6){ref-type="fig"}), a well-characterized phenotype that results from excessive and/or unregulated force generation ([@R4]; [@R11]; [@R61]). This degenerative disorder was observed with 100% penetrance in *Act88F^A295S^*/*Act88F^A295S^* homozygotes, where all endogenous wild-type IFM actin was replaced by the mutant variant, a finding consistent with impaired Tm-based inhibition of actomyosin interactions.

In an attempt to discern the mechanistic root of *ACTC1*-based cardiomyopathies, differences in the intrinsic biophysical properties of mutant actins, including folding and polymerization characteristics, have been investigated ([@R60]; [@R48]; [@R47]). Despite a lack of supportive in vitro evidence, the A295S substitution was predicted to alter actin stability and/or polymerization properties ([@R47]; [@R48]), which in vivo, could result in aberrant thin filament lengths. Thin filament length is an important determinant of force production ([@R19]). Mutations in skeletal muscle α-actin *ACTA1* that cause nemaline myopathy have been shown to alter thin filament length and force generation. Altered filament lengths may therefore contribute to the pathogenesis of A295S-mediated HCM. We measured thin filament lengths from confocal micrographs of TRITC-phalloidin-labeled IFM myofibrils ([Figure S4C](#SD1){ref-type="supplementary-material"}). Average thin filament length from two-day-old *w^1118^* (1.38 ± 0.01 μm), *Act88F^WT^*/+ (1.39 ± 0.01 μm), *Act88F^A295S^*/+ (1.39 ± 0.01 μm), *Act88F^WT^*/*Act88F^WT^* (1.39 ± 0.01 μm), and *Act88F^A295S^*/*Act88F^A295S^* (1.41 ± 0.01 μm) *Drosophila* did not significantly differ ([Figure 6B](#F6){ref-type="fig"}). These results were corroborated visually by image averaging of the TRITC-phalloidin actin signals from randomly selected IFM sarcomeres of each genotype ([Figure 6C](#F6){ref-type="fig"}), and they are consistent with unimpaired thin filament formation and stability, in vivo, irrespective of actin variant dose. Thus, disrupted thin filament length is likely not a contributing factor to *ACTC1* A295S-mediated pathology.

The A295S Actin Mutation Enhances Thin Filament Ca^2+^ Sensitivity {#S9}
------------------------------------------------------------------

To investigate the impact of the HCM mutation on molecular performance, homogeneous populations of transgenic actin were purified from the IFMs of *Act88F^WT^*/*Act88F^WT^* and *Act88F^A295S^*/*Act88F^A295S^ Drosophila* ([@R54]). Fluorescently labeled F-actin movement over immobilized rabbit skeletal myosin was studied in an in vitro motility assay ([@R32]). Unregulated velocities for Act88F^WT^ (2.77 ± 0.08 μm/s) and Act88F^A295S^ (2.80 ± 0.04 μm/s) F-actin were identical ([Figure 7A](#F7){ref-type="fig"}), which suggests the A295S lesion does not overtly influence actomyosin associations. We next reconstituted thin filaments using bovine cardiac Tn-Tm, in conjunction with rabbit skeletal, Act88F^WT^, or Act88F^A295S^ actin, to resolve potential differences in regulated motility ([@R40]). As previously reported, motility parameters of rabbit and Act88F^WT^ F-actin and reconstituted thin filaments were indistinguishable ([Figure S6](#SD1){ref-type="supplementary-material"}) ([@R6]), which justifies the use of IFM actin for investigating the molecular effects of human disease-causing mutations. Reconstituted Act88F^A295S^ thin filaments showed a leftward shift in the velocity:pCa (−log~10~of the calcium concentration) relationship relative to Act88F^WT^ thin filaments ([Figures 7B and 7C](#F7){ref-type="fig"}). The half-maximal pCa~50~ activation value was significantly higher for Act88F^A295S^ (6.23 ± 0.03) versus Act88F^WT^ (6.09 ± 0.05) regulated thin filaments, consistent with increased Ca^2+^ sensitivity. No significant differences, however, were observed in maximal sliding speed (3.26 ± 0.08 versus 3.23 ± 0.11 μm/s) or in the cooperativity of Ca^2+^ activation (n, Hill coefficient 1.77 ± 0.24 versus 1.26 ± 0.16) between mutant and control filaments. These data support an A295S actin-mediated gain in molecular thin filament function due to disrupted Tn-Tm-mediated regulation.

The A295S Actin Mutation Shifts the Electrostatic Equilibrium Position of Tropomyosin toward the Closed State {#S10}
-------------------------------------------------------------------------------------------------------------

An in silico approach was undertaken to identify molecular changes that may account for the hypercontractility of muscles and elevated Ca^2+^ sensitivity of thin filaments containing A295S actin. Landscapes of the electrostatic interaction energy between Tm and F-actin, which sample Tm energies over a range of azimuthal rotations and longitudinal translations around the actin filament axis, were calculated ([Figure 7D](#F7){ref-type="fig"}). The electrostatic interaction energy landscape for wild-type F-actin-Tm was characterized by a broad basin \~7 Å high and 8° wide. The basin exhibited a predominantly uniform and flat energy distribution. For example, the energy difference between the minimum configuration (X in [Figure 7D](#F7){ref-type="fig"}) and that of a previously assigned A/B state (circle in [Figure 7D](#F7){ref-type="fig"}) ([@R39]; [@R50]), both of which reside within the broad energy well, is miniscule. This implies that in the absence of Tn, Tm could access numerous locations within the basin with little energetic impediment. The A295S actin mutation, however, substantially changed the breadth of the F-actin-Tm energetic landscape. The energy basin of the mutant was narrower (\~5 Å high and 4° wide) and slightly deeper than that of wild-type, which resulted in a basin approximately 60% smaller in area. Therefore, Tm likely has fewer locations over the surface of A295S F-actin that are accessible with small energetic impediments. The mutant landscape also predicts that, on average, equilibrium positions of Tm are shifted upward toward the filament pointed end and azimuthally over the F-actin surface toward the actin inner domain, closer to the C state.

The minimized structures show that the total electrostatic energy difference observed between wild-type and mutant F-actin-Tm results from the cumulative effects of several small changes in the interactions of the A-triad with pseudo-repeats along Tm's entire length ([Figure S7](#SD1){ref-type="supplementary-material"}; [Table S3](#SD1){ref-type="supplementary-material"}). For instance, on average, the salt bridges formed between Tm and K328 and K326 on actin are 0.58 and 0.17 Å shorter in the mutant compared to wild-type, respectively ([Table S3](#SD1){ref-type="supplementary-material"}). Summation of the individual interaction values among R147, K326, and K328 of actin and acidic residues of Tm ([Table S4](#SD1){ref-type="supplementary-material"}) highlights that these associations, and in particular that of K328, account for nearly the entire difference in total electrostatic energy between wild-type and A295S F-actin-Tm. This suggests that the A-triad has a significant influence on, and is a major determinant of, Tm positioning. The A295S mutation appears to change A-triad-Tm interactions and thus the F-actin-Tm energetic landscape. The characteristic broad and flat energy basin, which helps properly position Tm for effective myosin blocking, is perturbed. Such mutation-induced effects in muscle could promote contractile disinhibition.

DISCUSSION {#S11}
==========

The A-triad is an ancient surface feature of actin. It is composed of K326, K328, and R147, which are among a large number of amino acids displaying 100% sequence identity ([Figure S1](#SD1){ref-type="supplementary-material"}). The extreme degree of conservation is believed to result from evolutionary constraints imposed by actin's interactions with a multitude of binding partners, which specify its function over a range of physiological processes ([@R23]; [@R53]). Here we provide in vivo evidence for a vital role of the A-triad residues in the fundamental process of Tn-Tm-mediated regulation of striated muscle contraction.

Previously, energy landscape determinations for Tm positioned over the surface of F-actin revealed the A-triad helps establish a broad energy basin associated with Tm favorably situated to block myosin binding ([@R50]). This configuration is close to that of the B state of Tn-Tm-regulated thin filaments but on average has greater positional variance ([@R37], [@R38]; [@R50]). We have now extended the in silico and in vitro findings and present data that support a direct role for these ground-state A-triad-Tm associations in steric hindrance of actomyosin cross-bridge cycling in the physiological context of muscle. We propose that in addition to TnI-actin binding, A-triad-Tm contacts are essential for force inhibition and that posttranslational modifications ([@R62]) or mutations to or around the A-triad can modulate contraction and can initiate disease.

The a\[α\]-cardiac actin A295S substitution, the first reported *ACTC1* mutation linked to HCM, occurs proximal to the A-triad ([@R45]). To unravel its molecular origin, we generated several transgenic *Drosophila* models of this highly penetrant disease. Our studies rely on technologies that provide distinct advantages over classical methodologies for investigating myopathies across a host of scales. While mouse models have been employed for such purposes, confounding genetic modifiers and environmental factors can influence and conceal pathology. For example, the clinical profile associated with the *ACTC1* A331P HCM mutation includes ventricular fibrillation, cardiac arrest, repolarization abnormalities, and hypertrophied walls, yet mice expressing the variant showed no phenotypic disruptions or signs of disease ([@R49]; [@R59]). Although the fly heart is less complex in gross structure relative to that of mammals, the ultrastructural and proteomic makeup are highly conserved ([@R13]). Defects in myofilament proteins, αB-crystallin, and the receptor tyrosine kinase pathway result in cardiac phenotypes remarkably similar to those characterized in human cardiomyopathy, suggesting conserved pathological responses also exist in *Drosophila* and that, accordingly, the fly can serve as an efficient translational disease model ([@R61]; [@R12]; [@R65]; [@R66]).

Our study employed the powerful *Drosophila* PhiC31 integrase-mediated transgenesis system to create HCM thin filament mutants ([@R22]). Integrase technology eliminates genetic variability and controls for expression inconsistency and modifying factors to help elucidate critical genotype-phenotype information that often eludes other models. In addition, flies permit evaluation of muscle performance from hundreds of animals, with tissue-specific expression, for exceptionally well-powered and highly controlled analyses. When expressed in the *Drosophila* heart, A295S actin incorporated uniformly along the length of thin filaments, reduced cardiac volumes especially at rest, and prolonged the duration of systolic tension development ([Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Restricted volumes and extended tension periods are consistent with impaired relaxation and the hyperdynamic contractile properties that precede myocardial hypertrophy ([@R21]) and that stimulate specific remodeling cascades ([@R18]). Diastolic dysfunction was further investigated by comparing relaxation responses in cardiac diameters to EGTA/EGTA,AM and subsequently to blebbistatin for control versus mutant hearts ([Figure 4](#F4){ref-type="fig"}). Changes in diameter are directly proportional to changes in opposing cell lengths. Diastole is normally characterized by slightly shortened myocytes with elevated basal stiffness ([@R61]) due to minor contributions from Ca^2+^-induced and, apparently, Ca^2+^-independent cross-bridge cycling ([Figure 4](#F4){ref-type="fig"}). However, our data suggest that the excessively shortened cardiomyocytes in quiescent *Hand* \> *Act57B^A295S^* hearts were not the result of elevated diastolic Ca^2+^ but rather were due to poor thin filament blocking of, and a disproportionately heightened number of disinhibited, actively cycling cross-bridges.

Heterozygous A295S actin expression in the IFM led to flight impairment, characterized by reduced acceleration ([Figure 5](#F5){ref-type="fig"}), which was likely secondary to force-induced microscopic damage. Such small hypercontractures can compromise performance at the level of the whole muscle and result in lower total IFM force generation during flight. Homozygous expression caused extensive macroscopic IFM damage and supported a variant-driven "gain of sarcomeric function," which resulted in a total lack of force production at the organismal level. The fibers were torn apart and displayed the typical hypercontraction phenotype ([Figure 6](#F6){ref-type="fig"}) associated with thin filament mutations that weaken Tm's ability to effectively block myosin cross-bridge cycling ([@R4]; [@R11]; [@R61]). The A295S actin mutation did not influence in vivo thin filament lengths or maximum F-actin sliding velocity ([Figures 6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}). These findings suggest that changes in force due to aberrant filament lengths or, as originally proposed, directly due to molecular deficiencies in actomyosin interactions ([@R45]) are not primary determinants of pathology. However, A295S-containing thin filaments, reconstituted from *Drosophila* actin and vertebrate cardiac Tn-Tm, displayed a significant increase in Ca^2+^ sensitivity, which is consistent with other HCM-inducing thin filament lesions ([@R57]) and with pathogenesis linked to impaired contractile regulation.

Disease-causing mutations frequently occur in residues at the F-actin-Tm interface. Such mutations likely interfere with electrostatic interactions between the proteins and distort the normal thin filament energy landscape. Because Tm location on F-actin is not fixed and can oscillate among the A/B, C, and M positions in either the absence or the presence of Ca^2+^, low-energy barriers are believed to separate distinct energy minima associated with each thin filament regulatory state ([@R43]; [@R42]; [@R52]). Therefore, relatively minor changes in surface interactions between F-actin and Tm could effectively alter these barriers to dramatically tip the balance between regulatory states ([@R36]; [@R52]; [@R34]). Energy landscape determinations predict that the *ACTC1* A295S HCM mutation induces numerous minor changes in the side-chain orientations of neighboring A-triad residues, which perturb its interaction with Tm and the aggregate F-actin-Tm energetic topology. Relative to the broad and flat energy basin found with wild-type F-actin-Tm, which helps establish the normal A/B state, the electrostatic energy landscape of A295S F-actin-Tm has a narrow and slightly deeper basin with a discrete minimum centered away from the A/B position and closer to the C position. Consequently, this may bias Tm away from locations impeding cross-bridge-actin interactions, thus promoting C-state occupancy for *ACTC1* A295S-containing thin filaments.

Our data, from the molecular through the tissue level, support a single unifying mechanism that explains the most proximal effects of the *ACTC1* A295S substitution and the development of HCM. In addition, they highlight a ubiquitous role for the neighboring A-triad in thin filament regulation and contractile relaxation of striated muscle. A295S-mediated pathology appears to result from propagated effects that structurally rearrange the A-triad and thus deform the energy basin that helps pin Tm in an inhibitory position. In our disease model, lower B-state occupancy of mutant thin filaments resulted in additional, unimpeded cross-bridge cycling, even in the absence of Ca^2+^, accounting for the restricted diastolic diameters of fly hearts. Furthermore, such inordinate myosin binding enhances Tn's affinity for Ca^2+^ ([@R58]; [@R46]; [@R25]). The thin filament would accordingly be primed and require less Ca^2+^-dependent movement of Tm and TnC-Ca^2+^ binding for activation. This is consistent with our findings of increased A295S thin filament Ca^2+^ sensitivity, which even in the absence of changes in Ca^2+^ handling, could prompt early onset and delay the completion of systole. In accordance with our results, these changes in vivo would manifest as prolonged SIs. Finally, altering intermolecular electrostatic A-triad-Tm interactions may influence deactivation. The A-triad likely facilitates the return of Tm to the energy basin that helps constrain it to an inhibitory position ([@R50]), which may also assist with TnI-actin docking and thus expedite the termination of force production. Disrupted A-triad-Tm interactions could thereby account for the inability of IFM thin filaments, in our mutant model, to properly turn off and inhibit tension, leading to destructive myosin-based force generation ([@R4]). Therefore, our findings increase comprehension of basic thin filament biology, demonstrate how the *ACTC1* A295S mutation triggers the early signs of HCM, and support the mechanistic model in which mutations that initiate hyperdynamic contraction and impaired relaxation result in pathological remodeling of the human heart ([@R21]; [@R18]).

EXPERIMENTAL PROCEDURES {#S12}
=======================

Multiple Sequence Alignment of Actins {#S13}
-------------------------------------

Amino acid sequence comparison of human and *Drosophila* cardiac and skeletal actins was performed using the Clustal Omega multiple sequence alignment program.

Structural Modeling {#S14}
-------------------

F-actin-Tm models ([@R39]) were generated using Chimera v.1.9 ([@R51]).

Construction of *UAS-Act57B* and *Act88F* Transgenes and Transgenic *Drosophila* {#S15}
--------------------------------------------------------------------------------

The *pUASp.Act57B^GFP.WT^* actin construct was provided by Dr. Katja Röper (Medical Research Council, Cambridge, UK). From this, the *Act57B^GFP.WT^* and *Act57B^WT^* cDNA sequences were spliced into the *pUASTattB* vector, behind 5 tandem UAS repeats (5×UAS), using the KpnI and XbaI and the NotI and XbaI restriction sites, respectively. *UAS-Act57B^GFP.A295S^* and *UAS-Act57B^A295S^* transgenes were generated by site-directed mutagenesis using the QuikChange Site-directed mutagenesis kit (Agilent Technologies) and custom synthesized primers:

1.  Forward primer: 5′-AAGGACCTGTACTCCAACATCGTCATG-3′

2.  Reverse primer: 5′-CATGACGATGTTGGAGTACAGGTCCTT-3′

The pattB *Act88F^WT^* genomic construct was provided by Dr. József Mihály (Hungarian Academy of Sciences, Budapest, Hungary). The pattB *Act88F^A295S^* mutant construct was created by Genetic Services (Sudbury, MA).

Transgenic *Drosophila* were generated using the PhiC31 integrase system as previously delineated ([@R62]).

*Drosophila* Stocks and Husbandry {#S16}
---------------------------------

Flies were raised at 25°C on a standard cornmeal-yeast-sucrose-agar medium. The *Hand^4.2^-Gal4* and the *Act88F* null (*ry^506^ KM88 e^s^*) lines were obtained from Drs. Rolf Bodmer (Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA) and John Sparrow (University of York, York, UK), respectively. For all *Gal4-UAS* crosses, *Hand^4.2^-Gal4* virgin females were mated with *UAS-Actin* males.

*Act88F* transgenic *Drosophila* had an endogenous actin gene (+) on each third chromosome, plus a transgene (*Act88F^WT^* or *Act88F^A295S^*) inserted into each second chromosome (i.e., *Act88F^WT^*/*Act88F^WT^*;+/+ or *Act88F^A295S^*/*Act88F^A295S^*;+/+). The transgenes were crossed into the *KM88* background by standard mating schemes using balancer chromosomes to generate *Act88F^WT^*/*Act88F^WT^*;*KM88*/*KM88* and *Act88F^A295S^*/*Act88F^A295S^*;*KM88*/*KM88* homozygous flies (designated as *Act88F^WT^*/*Act88F^WT^* and *Act88F^A295S^*/*Act88F^A295S^*, respectively). To generate heterozygotes, with one transgenic and one endogenous *Act88F* gene, homozygotes were crossed with *w^1118^* to create *Act88F^WT^*;*KM88*/+ and *Act88F^A295S^*;*KM88*/+ (designated as *Act88F^WT^*/+ and *Act88F^A295S^*/+).

Confocal Microscopy of the Fly Heart {#S17}
------------------------------------

*Hand* \> *Act57B^GFP.WT^* and *Hand* \> *Act57B^GFP.A295S^* cardiac tubes were prepared as detailed by [@R1] and imaged with a Leica TCS SPE RGBV confocal microscope.

To characterize the degree of overlap of GFP-labeled and TRITC-phalloidin-stained actin, images were analyzed using the ImageJ co-localization plugin. The average index of correlation ([@R28]) was calculated for cardiac sarcomeres of each genotype.

Cardiac Physiological Analysis {#S18}
------------------------------

One-, three-, five-, and seven-week-old, female *Hand ×yw*, *Hand* \> *Act57B^WT^*, and *Hand* \> *Act57B^A295S^* semi-intact *Drosophila* hearts were prepared under artificial hemolymph (AH) as described by [@R63]. Physiological parameters were assessed as formerly outlined ([@R15]; [@R7]), and significant differences between genotype and age, and interaction effects, were determined using two-way ANOVAs with Bonferroni post hoc tests.

Measurement of EGTA/EGTA,AM- and Blebbistatin-Induced Changes in Cardiac Dimensions {#S19}
-----------------------------------------------------------------------------------

Semi-intact hearts of three-week-old *Hand* × *yw*, *Hand* \> *Act57B^WT^*, and *Hand* \> *Act57B^A295S^* females were imaged and filmed as described by [@R61]. Beating hearts were recorded for 10 s in AH at various focal depths to resolve clear edges along the length of each tube. After initial filming, the AH was replaced with AH containing 10 mM EGTA and 100 μM EGTA,AM (AAT Bioquest). Following 30 min (25°C) to chelate extra- and intra-cellular Ca^2+^, the quiescent hearts were filmed as before and then incubated for 30 min in the same EGTA/EGTA,AM solution supplemented with 100 μM blebbistatin (Cayman Chemical). The hearts were re-imaged and filmed for a final time. Individual frames that clearly resolved the same region of both heart wall edges from videos taken under each condition were analyzed using HCImage Live software. Three distinct diameter measurements were made at identical locations along each tube from images obtained during diastole and under each treatment condition. These values were averaged for each animal and then for each genotype. The stepwise effects of EGTA/EGTA,AM and blebbistatin treatment on cardiac dimensions were evaluated using repeated-measures ANOVAs with Bonferroni multiple comparison tests of the matched groups. One-way ANOVAs followed by Bonferroni multiple comparison tests were used to distinguish significant differences in the cardiac responses (i.e., diameter changes) to EGTA/EGTA,AM and then to blebbistatin among genotypes.

Holography {#S20}
----------

Cinematic digital inline holography ([@R30]) was implemented to track flight trajectories of two-day-old *w^1118^* non-transgenic actin control, *Act88F^WT^*/+, and *Act88F^A295S^*/+ male and female *Drosophila*. 30 flies of a given genotype were released from the bottom of a 44.5 × 44.5 × 44.5 cm^3^ transparent acrylic enclosure maintained at 24°C. A halogen lamp was anchored above the chamber to entice upward flight. Data acquisition and analysis methods are described in [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"}, including sketches of the optical setup in [Figure S5A](#SD1){ref-type="supplementary-material"} and of the analysis in [Figure S5B](#SD1){ref-type="supplementary-material"}. Briefly, a sample volume of 11.6 × 11.6 × 44.5 cm^3^ was illuminated by a collimated pulsed neodymium-doped yttrium aluminum garnet (Nd:YAG) laser beam. The interference of light scattered from the flies with the undisturbed portions of the beam, the hologram, was recorded by a 2,016 × 2,016 pixels complementary metal-oxide semiconductor (CMOS) camera operating at 400 frames/s. Each run lasted 7.82 s, providing 3,128 holograms. The holograms were reconstructed numerically to obtain the intensity fields in a series of parallel planes. Multi-step detection procedures subsequently identified the in-focus location of each fly and tracked its displacement in time. The trajectories were used to calculate the kinematic properties of flight, including the velocity and acceleration vectors, as well as the angular velocity and the centripetal acceleration component, the latter signifying the fly's maneuverability. Significance was assessed by non-parametric Kruskal-Wallis one-way ANOVAs followed by Dunn's multiple comparison tests.

Indirect Flight Muscle and Sarcomere Imaging {#S21}
--------------------------------------------

Fluorescent microscopy was performed as in [@R62] to examine gross IFM morphology.

Myofibril imaging was carried out as previously described ([@R24]; [@R14]). Thin filament lengths were measured using ImageJ. Significance was assessed via the Kruskal-Wallis one-way ANOVA with Dunn's post hoc test.

For image averaging of sarcomeres, confocal micrographs of IFM myofibrils were imported into ImageJ. Individual myofibrils were straightened to fill a rectangular box by drawing a segmented line, of a width equal to the myofibril width, through its center and executing the Straighten command. Single sarcomeres were cropped and combined into an image stack. Images were aligned in x and y coordinate space using the plugin Template Matching → Align Slices in Stack (<https://sites.google.com/site/qingzongtseng/template-matching-ij-plugin>). A reference image was selected, and all images in the stack were translated to align in approximately the same position as the reference. Following automated image alignment, average sarcomere structures were generated by executing the Z Project command with the average intensity projection type.

Actin Purification from *Drosophila* Indirect Flight Muscle {#S22}
-----------------------------------------------------------

Act88F^WT^ and Act88F^A295S^ transgenic actin from \~40 IFMs was purified according to [@R54].

In Vitro Motility {#S23}
-----------------

Sliding of Act88F^WT^ and Act88F^A295S^ F-actin ([@R32]) and of Act88F^WT^ and Act88F^A295S^ thin filaments ([@R40]), over full-length rabbit skeletal myosin, was measured via standard modification of the in vitro motility assay. Thin filaments were reconstituted using bovine cardiac Tm and Tn. F-actin velocities measured in each of three replicate experiments were averaged, and the average velocities were pooled and weighted based on the number of filaments analyzed in each experiment. Significance was assessed by an unpaired t test. For Ca^2+^-regulated motility experiments, average filament velocities at each distinct \[Ca^2+^\] were pooled and weighted based on the number of filaments analyzed for each of six replicate experiments. Pooled velocity:Ca^2+^ data were re-plotted and fit to the Hill equation, and significant differences in fit parameters (V~max~, pCa~50~, and cooperativity) were determined via extra sum of squares F tests. See [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"} for further details.

Determination of F-Actin-Tropomyosin Energy Landscapes {#S24}
------------------------------------------------------

Energy landscapes for Tm and wild-type or A295S mutant F-actin were calculated as previously published ([@R55]) with minor modifications. Briefly, a model of Tm and F-actin was constructed. Tm was then azimuthally rotated and longitudinally translated to the grid points to be tested. This step can result in poor contacts that are unresolvable through minimization. Therefore, before minimization, Tm and actin side chains in proximity in the model were shrunk, and they were allowed to relax back during minimization. Constraints were applied in the minimization to keep the distance to actin and the overall shape of Tm consistent with known values for a Tm cable. All calculations were performed with CHARMM v.35b ([@R9]).

Statistical Methods {#S25}
-------------------

Statistical analysis was performed using GraphPad Prism 7.
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![The Actin A-Triad Is Highly Conserved and Forms Critical Electrostatic Interactions with Tropomyosin\
(A) Multiple sequence alignment of muscle actins from *Homo sapiens* and *Drosophila melanogaster*. ACTC, human α-cardiac muscle actin; ACTA, human a\[α\]-skeletal muscle actin; Act57B, *Drosophila* cardiac actin; Act88F, *Drosophila* IFM actin. Residues are shaded based on degree of conservation. An asterisk indicates positions that have identical residues, a colon indicates substitution with high structural similarity, and a period indicates substitution of low structural similarity. R147, K326, and K328, which form the A-triad, are shaded blue, and A295 is shaded yellow.\
(B) Molecular model of Tm (brown) on actin (blue) ([@R39]), illustrating electrostatic interactions between the A-triad and E139 and E142 of Tm. Inset: A295 is centered at the base of, and just behind, the actin A-triad.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms904147f1){#F1}

![Transgenic Actin Integrates Uniformly along *Drosophila* Cardiac Thin Filaments\
(A) Cardiac-restricted expression of *UAS-Act57B^GFP.WT^* actin was achieved via the *Hand^4.2^-Gal4* driver. GFP fluorescence emanated from cardiomyocytes of the heart tube (10× magnification). Scale bar, 100 μm.\
(B) Confocal micrographs taken at 40×magnification reveal Act57B^GFP.WT^ and Act57B^GFP.A295S^ transgenic actin incorporated discretely along cardiac myofibrils, as evident by striated GFP signals. Scale bar, 25 μm.\
(C) At 100× magnification, GFP-labeled actin appeared to overlap completely with TRITC-phalloidin (T-Ph) signals. Scale bar, 5 μm.\
(D) Fluorescent intensity line scans of cardiac myofibrils (imaged at 100×) illustrate well-aligned TRITC-phalloidin (red) and GFP (green) signals, indicating that the transgenic actin co-polymerized with endogenously expressed actin evenly along the length of cardiac thin filaments. The index of correlation, calculated as the fraction of positively correlated TRITC-phalloidin and GFP pixels from multiple *Hand* \> *Act57B^GFP.WT^* and *Hand* \> *Act57B^GFP.A295S^* sarcomeres (n = 85--97), was 0.82 and 0.78, respectively, reflecting a high degree of overlapping signals.](nihms904147f2){#F2}

![Expression of A295S Actin Reduces Cardiac Output and Engenders Restrictive Physiology with Prolonged Periods of Systolic Tension Development\
(A) M-mode kymograms generated from high-speed videos of beating three-week-old *Hand* \> *Act57B^WT^* and *Hand* \> *Act57B^A295S^* hearts. Vertical red lines delineate diastolic diameters and terminate at opposing edges of the heart wall.\
(B) Horizontal lines demarcate SIs (top) and complete HPs (bottom) for each genotype. Relative to transgenic *Act57B^WT^*-, *Act57B^A295S^*-expressing cardiac tubes displayed restricted diastolic diameters and prolonged systolic periods.\
(C) *Hand* \> *Act57B^A295S^ Drosophila* exhibited highly significant alterations in several cardiac functional parameters relative to *Hand* \> *Act57B^WT^* and *Hand* × *yw* control flies. Decreased output, cardiac dimensions, fractional shortening, and extended periods of systole were observed in the mutants at all ages studied.\
Data are presented as mean ± SEM (n = 35--46 for each genotype and age group). See also [Figure S2](#SD1){ref-type="supplementary-material"} and [Tables S1 and S2](#SD1){ref-type="supplementary-material"}.](nihms904147f3){#F3}

![Excessive Ca^2+^-Independent Actomyosin Associations during Diastole Promote Enhanced Myocyte Shortening and Incomplete Relaxation of *Hand* \> *Act57B^A295S^* Cardiomyocytes\
(A) M modes generated from the same region of a three-week-old *Hand* \> *Act57B^WT^* heart reveal graded responses of cardiac diameters following exposure to distinct small-molecule compounds. Red arrowheads indicate the position of the heart wall edges during diastole, upon incubation with EGTA/EGTA,AM, and finally, following the addition of blebbistatin. Incubation with EGTA/EGTA,AM resulted in complete cessation of wall motion. Relative to the diameter during diastole, each treatment induced a slight increase in diameter across the heart tube.\
(B) Significant, incremental increases in cardiac diameters were verified for all genotypes following extra- and intracellular Ca^2+^ chelation and upon blebbistatin incubation.\
(C) The average change in diameter across the heart wall in response to EGTA/EGTA,AM was similar among all lines.\
(D) Blebbistatin treatment prompted a significantly greater response across the wall of *Hand* \> *Act57B^A295S^* hearts relative to that observed for *Hand* × *yw* and *Hand* \> *Act57B^WT^* hearts.\
Data are presented as mean ± SEM (n = 21). \*\*\*p ≤ 0.001. See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms904147f4){#F4}

![A295S Actin Impairs *Drosophila* Flight Kinematics\
(A) Representative flight trajectories, and instantaneous acceleration values at every sampled point, for *w^1118^*, heterozygous *Act88F^WT^*/+, and heterozygous *Act88F^A295^*/+. *Act88F^A295S^*/+ mutants are characterized by low acceleration values over the length of their flight paths.\
(B) Probability distribution plots of velocity, angular velocity, acceleration, and centripetal acceleration for *w^1118^* (gray, n = 80), *Act88F^WT^*/+ (black, n = 90), and *Act88F^A295S^*/+ (red, n = 30) flies. While no difference in mean velocity or angular velocity was detected between *Act88F^WT^*/+ and *Act88F^A295S^*/+, both were significantly lower for each line relative to *w^1118^*. Moreover, no difference in acceleration during ascending flight was observed for *w^1118^* versus *Act88F^WT^*/+, while acceleration for the mutant line was significantly lower than that for both. Similarly, centripetal acceleration for *Act88F^A295S^*/+ was significantly lower than that for *w^1118^* and *Act88F^WT^*/+.\
See also [Figures S4 and S5](#SD1){ref-type="supplementary-material"}.](nihms904147f5){#F5}

![A295S Actin Promotes Indirect Flight Muscle Hyper-contraction without Altering Thin Filament Length\
(A) The dorsal longitudinal IFMs (DLMs) of two-day-old *Act88F^WT^*/+ and *Act88F^A295S^*/+ heterozygotes and of *Act88F^WT^*/*Act88F^WT^* homozygotes were indistinguishable from those of *w^1118^* controls. *Act88F^A295S^*/*Act88F^A295S^* homozygotes, however, displayed hypercontracted and torn DLMs.\
(B) The IFM thin filament lengths did not significantly differ among the lines. Data are presented as scatterplots that display the mean ± SEM for each genotype (n = 222--254).\
(C) Averaged composite images of sarcomeres (n = 47--89) from randomly selected myofibrils substantiated the similarities in thin filament lengths among the genotypes. Z and M denote Z- and M-line locations, respectively.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms904147f6){#F6}

![The A295S Actin Mutation Augments Thin Filament Ca^2+^ Sensitivity and Distorts the F-Actin-Tropomyosin Energy Landscape\
(A) Act88F^WT^ and Act88F^A295S^ F-actin, propelled by rabbit psoas muscle myosin, moved at identical velocities, which suggests the A295S mutation does not markedly affect actomyosin interactions. Average velocities for each of three biological replicate experiments (n = 3) were determined from 20 to 25 filaments per experiment. Bar graphs depict weighted mean velocity ± SEM.\
(B) Act88F^WT^ and Act88F^A295S^-containing thin filaments were reconstituted using bovine cardiac Tn-Tm. Three individual actin preparations were assayed twice (n = 6), and average velocities at each Ca^2+^ concentration, derived from 20 to 25 filaments per experiment, were pooled, plotted as a function of \[Ca^2+^\], and fit to the Hill equation. Act88F^WT^ and Act88F^A295S^ thin filament maximum velocities (V~max~), derived from the fits, were indistinguishable and used to normalize each pooled filament velocity. Normalized velocities ± SEM versus corresponding pCa values are presented.\
(C) The pCa~50~ of reconstituted thin filaments was significantly higher for Act88F^A295S^ relative to Act88F^WT^ filaments, indicative of augmented Ca^2+^sensitivity. Bar graphs depict pCa~50~ values ± SEM calculated from the fits. \*p = 0.015.\
(D) Electrostatic interaction energy landscapes of Tm rotated and translated over the surface of wild-type F-actin (left) and A295S mutant F-actin (right). The color is scaled as indicated on the right axis. Energy values in each graph are relative to the minimum point in the landscape, which was set to zero. The total minimum energy for the wild-type is higher than that for the mutant (−2,165 versus −2,221 kcal/mol, respectively). The minima of the landscapes are denoted with a white X. The position of Tm in the [@R39] A/B state is indicated by a white circle for reference ([@R50]). Contours on the plots start at 100 kcal/mol and increase by 200 kcal/mol.\
See also [Figures S6 and S7](#SD1){ref-type="supplementary-material"} and [Tables S3 and S4](#SD1){ref-type="supplementary-material"}.](nihms904147f7){#F7}

###### Highlights

-   The highly conserved actin A-triad consists of residues K326, K328, and R147

-   A-triad-tropomyosin interactions along thin filaments promote muscle relaxation

-   *Drosophila* cardiomyopathy models illustrate the A-triad's significance in vivo

-   Distortion of the A-triad can trigger hypercontraction and disease
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